Xiang JI, Jie ZHOU, Wenting WU, Yan TANG, Tongrong XU

Application of high-flow oxygen therapy in acute pancreatitis complicated with acute respiratory dysfunction

Background/aim: To reveal the potential efficiency of high-flow oxygen therapy in acute pancreatitis complicated with acute respiratory dysfunction compared with conventional oxygen therapy. Materials and methods: We retrospectively analyzed 69 patients treated with high-flow oxygen or conventional oxygen therapy, then compared the difference of prime and second outcomes between the two groups. Results: The high-flow oxygen group had lower intubation rate (25.6% vs. 56.7%, p = 0.013) and longer median time to intubation (64.25 h vs. 7.75 h, p < 0.001) compared with the conventional oxygen group. High-flow oxygen had a stronger effect on improving dyspnea (87.2% vs. 56.7%, p = 0.006) and regression of respiratory failure (66.7% vs. 26.7%, p = 0.001). In the univariate and multivariate analyses, high-flow oxygen and APACHE II score were independent predict factors to respiratory failure regression (OR = 20.381, p = 0.038; OR = 36.827, p = 0.026). Patients treated with high-flow oxygen had shorter intensive care unit stay length (19.5 ± 13.4 vs. 7.8 ± 4.7, p = 0.009) and early mortality tended to be significantly lower (17.9% vs. 40.0%, p = 0.058). Conclusion: High-flow oxygen is a more effective method for acute pancreatitis complicated with acute respiratory dysfunction than conventional oxygen therapy.

PDF

___

1. Imrie CW, Ferguson JC, Murphy D, Blumgart LH. Arterial hypoxia in acute pancreatitis. British Journal of Surgery 1977; 64 (3): 185-188. doi: 10.1002/bjs. 1800640310
2. Steinberg W, Tenner S. Acute pancreatitis. New England Journal of Medicine 1994; 330 (17): 1198-1210. doi: 10.1056/ NEJM199404283301706
3. Baron TH, Morgan DE. Acute necrotizing pancreatitis. New England Journal of Medicine 1999; 340 (18): 1412-1417. doi: 10.1056/NEJM199905063401807
4. Wyncoll DL. The management of severe acute necrotising pancreatitis: an evidence-based review of the literature. Intensive Care Medicine 1999; 25 (2): 146-156. doi: 10.1007/ s001340050808
5. Shields CJ, Winter DC, Redmond HP. Lung injury in acute pancreatitis: mechanisms, prevention, and therapy. Current Opinion in Critical Care 2002; 8 (2): 158-163. doi: 10.1097/00075198-200204000-00012
6. Pastor CM, Matthay MA, Frossard JL. Pancreatitis-associated acute lung injury: new insights. Chest 2003; 124 (6): 2341- 2351. doi: 10.1378/chest.124.6.2341
7. Andersson R, Andersson B, Haraldsen P, Drewsen G, Eckerwall G. Incidence, management and recurrence rate of acute pancreatitis. Scandinavian Journal of Gastroenterology 2004; 39 (9): 891-894. doi: 10.1080/00365520410007061
8. McKay CJ, Evans S, Sinclair M, Carter CR, Imrie CW. High early mortality rate from acute pancreatitis in Scotland, 1984- 1995. British Journal of Surgery 1999; 86 (10): 1302-1305. doi: 10.1046/j.1365-2168.1999.01246.x
9. Blum T, Maisonneuve P, Lowenfels AB, Lankisch PG. Fatal outcome in acute pancreatitis: its occurrence and early prediction. Pancreatology 2001; 1 (3): 237-241. doi: 10.1159/000055817
10. Andersson R, Andren-Sandberg A. Fatal acute pancreatitis. Characteristics of patients never reaching hospital. Pancreatology 2003; 3 (1): 64-66. doi: 10.1159/0000 55817
11. Halonen KI, Leppaniemi AK, Puolakkainen PA, Lundin JE, Kemppainen EA et al. Severe acute pancreatitis: prognostic factors in 270 consecutive patients. Pancreas 2000; 21 (3): 266- 271. doi: 10.1097/00006676-200010000-00008
12. Jaber S, Chanques G, Sebbane M, Salhi F, Delay JM et al. Noninvasive positive pressure ventilation in patients with respiratory failure due to severe acute pancreatitis. Respiration 2006; 73 (2): 166-172. doi: 10.1159/000088897
13. Besnier E, Hobeika S, S NS, Lambiotte F, Du Cheyron D et al. High-flow nasal cannula therapy: clinical practice in intensive care units. Annals of Intensive Care 2019; 9 (1): 98. doi: 10.1186/ s13613-019-0569-9
14. Zemach S, Helviz Y, Shitrit M, Friedman R, Levin PD. The Use of High-Flow Nasal Cannula Oxygen Outside the ICU. Respiratory Care 2019; 64 (11): 1333-1342. doi: 10.4187/respcare.06611
15. Roca O, Riera J, Torres F, Masclans JR. High-flow oxygen therapy in acute respiratory failure. Respiratory Care 2010; 55 (4): 408-413.
16. Frat JP, Brugiere B, Ragot S, Chatellier D, Veinstein A et al. Sequential application of oxygen therapy via high-flow nasal cannula and noninvasive ventilation in acute respiratory failure: an observational pilot study. Respiratory Care 2015; 60 (2): 170- 178. doi: 10.4187/respcare.03075
17. Dysart K, Miller TL, Wolfson MR, Shaffer TH. Research in high flow therapy: mechanisms of action. Respiratory Medicine 2009; 103 (10): 1400-1405. doi: 10.1016/j.rmed.2009.04.007
18. Rochwerg B, Granton D, Wang DX, Helviz Y, Einav S et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Medicine 2019; 45 (5): 563-572. doi: 10.1007/s00134-019-05590-5
19. Zhu Y, Yin H, Zhang R, Ye X, Wei J. High-flow nasal cannula oxygen therapy versus conventional oxygen therapy in patients after planned extubation: a systematic review and meta-analysis. Critical Care 2019; 23 (1): 180. doi: 10.1186/s13054-019-2465-y
20. Milesi C, Essouri S, Pouyau R, Liet JM, Afanetti M et al. High flow nasal cannula (HFNC) versus nasal continuous positive airway pressure (nCPAP) for the initial respiratory management of acute viral bronchiolitis in young infants: a multicenter randomized controlled trial (TRAMONTANE study). Intensive Care Medicine 2017; 43 (2): 209-216. doi: 10.1007/s00134-016- 4617-8
21. Delclaux C, L’Her E, Alberti C, Mancebo J, Abroug F et al. Treatment of acute hypoxemic nonhypercapnic respiratory insufficiency with continuous positive airway pressure delivered by a face mask: A randomized controlled trial. Journal of the American Medical Association 2000; 284 (18): 2352-2360. doi: 10.1001/jama.284. 18.2352
22. Gregoretti C, Confalonieri M, Navalesi P, Squadrone V, Frigerio P et al. Evaluation of patient skin breakdown and comfort with a new face mask for non-invasive ventilation: a multi-center study. Intensive Care Medicine 2002; 28 (3): 278-284. doi: 10.1007/s00134-002-1208-7
23. Frat JP, Thille AW, Mercat A, Girault C, Ragot S et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. New England Journal of Medicine 2015; 372 (23): 2185- 2196. doi: 10.1056/NEJMoa1503326
24. Frat JP, Ragot S, Girault C, Perbet S, Prat G et al. Effect of non-invasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure: a post-hoc analysis of a randomised trial. The Lancet Respiratory Medicine 2016; 4 (8): 646-652. doi: 10.1016/S2213-2600(16)30093-5
25. Coudroy R, Jamet A, Petua P, Robert R, Frat JP et al. High-flow nasal cannula oxygen therapy versus noninvasive ventilation in immunocompromised patients with acute respiratory failure: an observational cohort study. Annals of Intensive Care 2016; 6 (1): 45. doi: 10.1186/s13613-016-0151-7
26. Sklar MC, Mohammed A, Orchanian-Cheff A, Del Sorbo L, Mehta S et al. The Impact of High-Flow Nasal Oxygen in the Immunocompromised Critically Ill: A Systematic Review and Meta-Analysis. Respiratory Care 2018; 63 (12): 1555-1566. doi: 10.4187/respcare.05962
27. Werner J, Feuerbach S, Uhl W, Buchler MW. Management of acute pancreatitis: from surgery to interventional intensive care. Gut 2005; 54 (3): 426-436. doi: 10.1136/gut.2003.035907